These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 6839062)

  • 1. Comparison of the effects of the hypolipidaemic agents ICI53072 and clofibrate with those of phenobarbitone on liver size, blood flow and DNA content in the rat.
    Berman JS; Hiley CR; Wilson AC
    Br J Pharmacol; 1983 Mar; 78(3):533-41. PubMed ID: 6839062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of hypolipidemic agents on the hepatic microsomal drug-metabolizing enzyme system of the rat. Induction of cytochrome(s) P-450 with specificity toward terminal hydroxylation of lauric acid.
    Orton TC; Parker GL
    Drug Metab Dispos; 1982; 10(2):110-5. PubMed ID: 6124394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat.
    Amacher DE; Beck R; Schomaker SJ; Kenny CV
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):143-50. PubMed ID: 9007043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of serum triglyceride lowering to changes in hepatic composition induced by different classes of drugs.
    Dalton C; Hope WC; Hope HR; Sheppard H
    Biochem Pharmacol; 1974 Feb; 23(3):685-96. PubMed ID: 4150813
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the hepatomegaly caused by the hypolipidemic drugs nafenopin and clofibrate.
    Beckett RB; Weiss R; Stitzel RE; Cenedella RJ
    Toxicol Appl Pharmacol; 1972 Sep; 23(1):42-53. PubMed ID: 5071041
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytochrome P-450 induction by clofibrate. Purification and properties of a hepatic cytochrome P-450 relatively specific for the 12- and 11-hydroxylation of dodecanoic acid (lauric acid).
    Gibson GG; Orton TC; Tamburini PP
    Biochem J; 1982 Apr; 203(1):161-8. PubMed ID: 7103935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic effect of two hypolipidemic drugs in rats.
    Magnusson G; Magnusson O
    Exp Pathol (Jena); 1977; 13(2-3):180-7. PubMed ID: 913535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of single and concurrent clofibrate and phenobarbital administration on cytochrome P450-dependent mixed function oxidase activities and peroxisome proliferation in male rat liver.
    Close I; Shackleton G; Goldfarb PS; Gibson GG; Sharma R; Howes D
    J Biochem Toxicol; 1992; 7(3):193-8. PubMed ID: 1479597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of four hypolipidaemic agents on the activity of drug-metabolizing enzymes in rat liver microsomes.
    Fournel S; Magdalou J; Batt AM; Siest G
    Int J Clin Pharmacol Res; 1983; 3(6):431-6. PubMed ID: 6432712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of benzodioxane, chroman, and dihydrobenzofuran analogs of clofibrate on various parameters of hepatic drug metabolism.
    Lewis NJ; Feller DR; Poochikian GK; Witiak DT
    J Med Chem; 1974 Jan; 17(1):41-5. PubMed ID: 4808468
    [No Abstract]   [Full Text] [Related]  

  • 11. Phenobarbitone effects on hepatic microsomal enzymes and liver blood flow in the guinea pig.
    Yates MS; Hiley CR; Challiner MR; Park BK
    Biochem Pharmacol; 1979 Sep; 28(18):2856-7. PubMed ID: 497037
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of several antilipemic agents on the activity of liver microsomal enzymes].
    Mounié J; Goudonnet H; Escousse A; Truchot RC
    J Pharmacol; 1986; 17(3):308-15. PubMed ID: 3491930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of tiadenol, clofibrate and clofibride on bile composition in the rat.
    Rozé C; Cuchet P; Souchard M; Vaille C; Debray C
    Eur J Pharmacol; 1977 May; 43(1):57-64. PubMed ID: 862664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of phenobarbitone on hepatic microsomal enzyme activity and liver blood flow in spontaneously hypertensive rats.
    Yates MS; Hiley CR; Back DJ
    Life Sci; 1979 Feb; 24(6):535-40. PubMed ID: 431334
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential effects of dehydroepiandrosterone and clofibrate on the binding of 7,12-dimethyl benz(a)anthracene to hepatic DNA in vivo--a preliminary study.
    Prasanna HR; Hart RW; Magee PN
    Drug Chem Toxicol; 1989; 12(3-4):327-35. PubMed ID: 2534380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hypolipidaemic drugs on hepatomegaly and micro-bodies in the rat. A new approach to the nature of hepatic peroxisomal proliferation.
    Sim AK; Spencer A; Metz G; Rushton B
    Arzneimittelforschung; 1981; 31(7):1119-26. PubMed ID: 7196761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of alteration of hepatic microsomal enzyme activity on liver blood flow in the rat.
    Nies AS; Wilkinson GR; Rush BD; Strother JR; McDevitt DG
    Biochem Pharmacol; 1976 Sep; 25(17):1991-3. PubMed ID: 985528
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of phenobarbitone and 6-methylprednisolone pretreatment on pressure/flow relations in the superior mesenteric and iliac arterial beds of the rat.
    Hiley CR; Nichols AJ; Wilson AC
    J Pharm Pharmacol; 1985 Mar; 37(3):164-9. PubMed ID: 2858562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver blood flow and blood volume following chronic phenobarbitone administration.
    Ohnhaus EE; Locher JT
    Eur J Pharmacol; 1975 Apr; 31(2):161-5. PubMed ID: 1149789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of clofibrate and tiadenol on the elimination of lipids and bile acids in rat bile.
    Cuchet P; Morrier C; Cand F; Keriel C
    Lipids; 1981 Oct; 16(10):732-8. PubMed ID: 7300592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.